GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide
So, what's the deal with GIP, you might ask
Post-marketing reports suggest hair thinning may occur, particularly with substantial weight loss, but this likely represents telogen effluvium triggered by metabolic changes rather than direct drug toxicity
That could also be whats happening in this case, Corley, from UC-San Diego, suggested
Assessment of body composition in health and disease using bioelectrical impedance analysis (BIA) and dual energy X-ray absorptiometry (DXA): a critical overview
Cheng H, Zhang Z, Zhang B, et al